Aliases & Classifications for West Nile Fever

About this section

Aliases & Descriptions for West Nile Fever:

Name: West Nile Fever 11 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:2366
ICD1030 A92.3, A92.30
SNOMED-CT62 12381007, 417093003
ICD9CM32 066.4, 066.40
MeSH39 D014901

Summaries for West Nile Fever

About this section
Disease Ontology:11 A viral infectious disease that results in infection, has material basis in West Nile virus, which is transmitted by Culex and transmitted by Aedes mosquitoes. The infection has symptom fever, has symptom sore throat, has symptom headache, has symptom body ache, has symptom nausea, has symptom maculopapular rash and has symptom vomiting.

MalaCards based summary: West Nile Fever is related to japanese encephalitis and west nile virus, and has symptoms including fever, sore throat and headache. An important gene associated with West Nile Fever is RPS29 (Ribosomal Protein S29), and among its related pathways is Defensins. The drug ribavirin has been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and lymph node, and related mouse phenotype Decreased shRNA abundance (Z-score < -2).

Wikipedia:71 West Nile fever is a mosquito-borne infection by the West Nile virus. Approximately 80% of West Nile... more...

Related Diseases for West Nile Fever

About this section

Diseases related to West Nile Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 16)
idRelated DiseaseScoreTop Affiliating Genes
1japanese encephalitis29.1CD40LG, STAB2
2west nile virus11.8
3west nile encephalitis11.6
4encephalitis10.2
5rift valley fever9.9
6stiff-person syndrome9.8
7chikungunya9.8
8acute pancreatitis9.8
9newcastle disease9.8
10myelitis9.8
11pancreatitis9.8
12tremor9.8
13discharging ear9.8CD40LG, STAB2
14malignant hypertension9.7CD40LG, STAB2
15retinal perforation9.6CD40LG, DEFA1
16secretory diarrhea9.5CD40LG, STAB2

Graphical network of diseases related to West Nile Fever:



Diseases related to west nile fever

Symptoms & Phenotypes for West Nile Fever

About this section

Symptoms:

 11 (show all 7)
  • fever
  • sore throat
  • headache
  • body ache
  • nausea
  • maculopapular rash
  • vomiting

GenomeRNAi Phenotypes related to West Nile Fever according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-588.7DEFA1, DEFA3, RPS29

Drugs & Therapeutics for West Nile Fever

About this section

Drugs for West Nile Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
FludarabineapprovedPhase 3111321679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ARAA
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-fluoro ARA-A
21679-14-1
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
Fludara, Fludarabine
 
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
2
Cyclophosphamideapproved, investigationalPhase 3282950-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
3
rituximabapprovedPhase 31654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
4
VidarabineapprovedPhase 351224356-66-932326, 21704
Synonyms:
(+)-Cyclaradine
.beta.-Adenosine
.beta.-D-Adenosine
1odi
2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2946-52-3
2fqy
2gl0
30143-02-3
3080-29-3
3228-71-5
4005-33-8
46946-45-6
46969-16-8
524-69-6
5536-17-4
58-61-7
9-Arabinosyladenine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl-adenine
9-β-D-arabinofuranosyl-9H-purin-6-amine
9-β-D-arabinofuranosyladenine
A 9251
A0152
A4036_SIGMA
A4676_SIGMA
A5762_SIGMA
A9251_SIGMA
AC1L18OL
AC1L1U8O
AC1L2IWM
AC1L2SCM
AC1O4WIN
AC1O8PY7
AC1Q1ID3
AC1Q4Y1Z
AC1Q52XU
ADENOSINE, U.S.P.
ADN
AI3-52413
AI3-52821
AR-1H6029
ARA-A NSC 247519
Ade-Rib
Adenine Arabinoside
Adenine arabinoside
Adenine nucleoside
Adenine riboside
Adenine xyloside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine arabinose
Adenosine-8-14C
Adensoine
Ambap5536-17-4
Ara A
Ara-A
Ara-ATP
Araadenosine
Arabinoside Adenine
Arabinoside adenine
Arabinosyl Adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
BB_NC-0565
BPBio1_000898
BRN 0624881
BSPBio_000816
BSPBio_001796
BSPBio_002000
Bio1_000437
Bio1_000926
Bio1_001415
Boniton
C00212
CAS-5536-17-4
CCRIS 2557
CCRIS 3383
CHEBI:136932
CHEBI:16335
CHEBI:45327
CHEMBL1090
CHEMBL20247
CHEMBL477
CI 673
CI-673
CID102198
CID191
CID21704
CID60961
CID6420052
CID6713976
CPD000471872
Caswell No. 010B
D000241
D00045
D06298
DB00640
DivK1c_000191
EINECS 200-389-9
EINECS 217-911-6
EINECS 226-893-9
EU-0100123
FT-0082881
HMS1570I18
HMS1920A13
HMS1921K05
HMS2090F06
HMS2091G13
HMS2092C16
HMS500J13
HSDB 6514
 
I01-1121
IDI1_000191
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001296
KBio3_001500
KBioGR_001224
KBioSS_002424
L000094
LS-15059
LS-15085
Lopac0_000123
MEDR-640
MLS000069638
MLS000699527
MLS001066352
MLS001333133
MLS001333134
MLS002153227
MLS002153992
MolPort-001-785-903
MolPort-001-838-229
MolPort-003-666-308
Myocol
NCGC00016656-01
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
NCGC00178869-01
NCGC00179417-01
NCI60_003823
NCI60_037192
NCIOpen2_003303
NCIOpen2_005376
NINDS_000191
NSC 247519
NSC 404241
NSC 627048
NSC 7359
NSC 7652
NSC-404241
NSC247519
NSC404241
NSC627048
NSC70422
NSC7359
NSC7652
NSC80832
NSC87676
NSC91041
Nucleocardyl
PDSP1_001036
PDSP2_001020
Pallacor
Polyadenosine
Polyriboadenosine
Prestwick0_000768
Prestwick1_000768
Prestwick2_000768
Prestwick3_000768
Prestwick_983
RAB
S1647_Selleck
S1784_Selleck
SAM002564191
SMP1_000312
SMR000058216
SMR000225041
SMR000471872
SMR001233326
SPBio_001194
SPBio_001491
SPBio_002755
SPECTRUM1500107
SPECTRUM1500609
SR 96225
SR-96225
STK361815
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum2_001336
Spectrum3_000288
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spectrum_001894
Spongoadenosine
TL8003749
UNII-3XQD2MEW34
UNII-K72T3FS567
USAF CB-10
V0098
VIRDARABINE
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine
Vidarabine (JAN)
Vidarabine anhydrous
Vidarabinum
Vira ATM
Vira-A
Vira-A, Vidarabine
XA
Xylosyl A
Xylosyladenine
ZINC00970363
ZINC02169830
adenine-D-ribose
adenosine
alpha-Ara A
beta-Adenosine
beta-Ara A
beta-D-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.64-comp4
nchembio706-5
5AntimetabolitesPhase 3, Phase 211774
6Antiviral AgentsPhase 3, Phase 29732
7Anti-Infective AgentsPhase 3, Phase 221402
8Heptavalent Pneumococcal Conjugate VaccinePhase 3, Phase 2454
9ImmunoglobulinsPhase 3, Phase 2, Phase 16045
10VaccinesPhase 3, Phase 2, Phase 16428
11AntibodiesPhase 3, Phase 2, Phase 16045
12Antineoplastic Agents, AlkylatingPhase 34474
13Vidarabine PhosphatePhase 3124
14Alkylating AgentsPhase 34694
15Immunosuppressive AgentsPhase 312770
16Antibodies, MonoclonalPhase 3, Phase 23795
17Antirheumatic AgentsPhase 310627
18Antimetabolites, AntineoplasticPhase 37171
19
RibavirinapprovedPhase 298436791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
NSC 163039
 
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
20
DabrafenibapprovedPhase 27944462760, 44516822
Synonyms:
BRAF inhibitor GSK2118436
Dabrafenib
 
GSK2118436
GSK2118436a
Tafinlar
dabrafenib
21
TrametinibapprovedPhase 2121871700-17-311707110
Synonyms:
GSK 1120212
GSK1120212
JTP 74057
JTP-74057
 
MEK Inhibitor GSK1120212
Mekinist
Trametinib Dimethyl Sulfoxide
Trametinibum
trametinib
22
Glycineapproved, nutraceutical, vet_approvedPhase 1, Phase 222656-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
23Rho(D) Immune GlobulinPhase 1, Phase 2317
24Immunoglobulins, IntravenousPhase 1, Phase 2324
25gamma-GlobulinsPhase 1, Phase 2317
26Immunoglobulin GPhase 1, Phase 2265
27Pharmaceutical SolutionsPhase 2, Phase 17793
28Protein Kinase InhibitorsPhase 23612

Interventional clinical trials:

(show all 21)
idNameStatusNCT IDPhase
1Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
2Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT02048813Phase 3
3Treatment of Japanese EncephalitisUnknown statusNCT00216268Phase 2
4Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy AdultsCompletedNCT00746798Phase 2
5Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy AdultsCompletedNCT00442169Phase 2
6IVIG - West Nile Encephalitis: Safety and EfficacyCompletedNCT00068055Phase 1, Phase 2
7Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus DiseaseCompletedNCT00069316Phase 2
8Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of AgeCompletedNCT00578175Phase 2
9Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by SurgeryRecruitingNCT02196181Phase 2
10Treatment of West Nile Virus With MGAWN1TerminatedNCT00927953Phase 2
11Phase I Study of West Nile Virus VaccineCompletedNCT00300417Phase 1
12Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy AdultsCompletedNCT00537147Phase 1
13Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy AdultsCompletedNCT00094718Phase 1
14Vaccine to Prevent West Nile Virus DiseaseCompletedNCT00106769Phase 1
15Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020CompletedNCT00387283Phase 1
16An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) DiseaseTerminatedNCT00091845Phase 1
17Natural History of West Nile Virus InfectionCompletedNCT00069303
18West Nile Virus Natural HistoryCompletedNCT00138463
19Surveillance of Summer Febrile Syndromes of Viral Origin in South of FranceCompletedNCT00842166
20Cohort of Patients Infected by an ArbovirusRecruitingNCT01099852
21Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental ExposureNo longer availableNCT01206504

Search NIH Clinical Center for West Nile Fever

Inferred drug relations via UMLS68/NDF-RT46:

Genetic Tests for West Nile Fever

About this section

Anatomical Context for West Nile Fever

About this section

MalaCards organs/tissues related to West Nile Fever:

36
Spinal cord, Brain, Lymph node

Publications for West Nile Fever

About this section

Articles related to West Nile Fever:

(show top 50)    (show all 64)
idTitleAuthorsYear
1
Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry. (27342050)
2016
2
Outbreaks of West Nile fever in France. (26405120)
2015
3
WEST NILE FEVER IN BRAZIL: SPORADIC CASE, SILENT ENDEMIC DISEASE OR EPIDEMIC IN ITS INITIAL STAGES? (26200972)
2015
4
ECDC publishes new interactive online tool: West Nile fever maps for 2015. (26062647)
2015
5
Clinical Sentinel Surveillance of Equine West Nile Fever, Spain. (24899369)
2014
6
Environmental predictors of West Nile fever risk in Europe. (24986363)
2014
7
Human and entomological surveillance of West Nile fever, dengue and chikungunya in Veneto Region, Italy, 2010-2012. (24499011)
2014
8
West Nile fever in Israel: The reemergence of an endemic disease. (24183889)
2014
9
Mapping the Serological Prevalence Rate of West Nile fever in Equids, Tunisia. (23906318)
2013
10
Can horses be clinically screened for West Nile Fever? (23292842)
2013
11
Permissive summer temperatures of the 2010 European West Nile fever upsurge. (23431374)
2013
12
Environmental drivers of West Nile fever epidemiology in Europe and Western Asia--a review. (23939389)
2013
13
Animal viral diseases and global change: bluetongue and West Nile fever as paradigms. (22707955)
2012
14
Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. (20687860)
2011
15
Clinical diagnosis of West Nile Fever in Equids by classification and regression tree (CART) analysis and comparative study of clinical appearance in three European countries. (21208395)
2011
16
West Nile fever outbreak in horses and humans, Spain, 2010. (22172565)
2011
17
Temporal distribution and spatial pattern of abundance of the Rift Valley fever and West Nile fever vectors in Barkedji, Senegal. (22129415)
2011
18
Differential West Nile fever ascertainment in the United States: a multilevel analysis. (20889867)
2010
19
West Nile fever characteristics among viremic persons identified through blood donor screening. (20874087)
2010
20
Evaluation of the efficiency of bird-baited traps for sampling potential West Nile fever mosquito vectors (Diptera: Culicidae) in Senegal. (20597441)
2010
21
Where is West Nile fever? Lessons learnt from recent human cases in northern Italy. (19317987)
2009
22
Influence of warming tendency on Culex pipiens population abundance and on the probability of West Nile fever outbreaks (Israeli Case Study: 2001-2005). (18648796)
2008
23
West Nile fever in a patient in Romania, August 2008: case report. (18822244)
2008
24
Persistent neurobehavioral signs and symptoms following West Nile fever. (18305310)
2008
25
Mosquito vectors of West Nile Fever in Israel. (18826039)
2008
26
West Nile viremic blood donors and risk factors for subsequent West Nile fever. (17979539)
2007
27
Maculopapular rash and tremor are associated with West Nile fever and neurological syndromes. (17435190)
2007
28
Serological assessment of West Nile fever virus activity in the pastoral system of Ferlo, Senegal. (17135514)
2006
29
Rehabilitation of West Nile Fever (WNF) encephalitis in elderly. (15911034)
2005
30
Post-epidemic serosurvey of West Nile fever in Israel. (16362810)
2005
31
Epidemiological processes involved in the emergence of vector-borne diseases: West Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever. (15702718)
2004
32
Mass media-induced availability bias in the clinical suspicion of West Nile fever. (14757629)
2004
33
Stiff-person syndrome following West Nile fever. (15210535)
2004
34
Clinical characteristics and functional outcomes of West Nile Fever. (15353427)
2004
35
Summaries for patients. Clinical characteristics and consequences of West Nile Fever. (15353444)
2004
36
Death from the Nile crosses the Atlantic: the West Nile Fever story. (14723356)
2003
37
West Nile fever: lessons from the 2002 season. (12779134)
2003
38
Morphofunctional characteristics of antigen-presenting cells in lymph node in mice with experimental West Nile fever. (12802405)
2003
39
Outcome of West Nile fever in older adults. (12410904)
2002
40
Use of live and inactivated vaccines in the control of West Nile fever in domestic geese. (11797782)
2001
41
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. (11585531)
2001
42
West Nile fever: here to stay and spreading. (11405618)
2001
43
West Nile fever outbreak, Israel, 2000: epidemiologic aspects. (11585533)
2001
44
Comparative symptomatology of West Nile fever. (11498205)
2001
45
Rhombencephalitis caused by West Nile fever virus. (10891935)
2000
46
West Nile fever heads north. (11033722)
2000
47
West Nile fever in New York City. (10763405)
2000
48
West Nile fever in the United States. (12876824)
2000
49
An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. (10674664)
1999
50
West Nile fever--a reemerging mosquito-borne viral disease in Europe. (10511520)
1999

Variations for West Nile Fever

About this section

Expression for genes affiliated with West Nile Fever

About this section
Search GEO for disease gene expression data for West Nile Fever.

Pathways for genes affiliated with West Nile Fever

About this section

Pathways related to West Nile Fever according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.1DEFA1, DEFA3

GO Terms for genes affiliated with West Nile Fever

About this section

Cellular components related to West Nile Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.9CD40LG, STAB2
2azurophil granule lumenGO:00355789.8DEFA1, DEFA3
3Golgi lumenGO:00057969.1DEFA1, DEFA3

Biological processes related to West Nile Fever according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1antibacterial humoral responseGO:00197319.8DEFA1, DEFA3
2defense response to fungusGO:00508329.8DEFA1, DEFA3
3defense response to Gram-positive bacteriumGO:00508309.7DEFA1, DEFA3
4defense response to virusGO:00516079.6DEFA1, DEFA3
5innate immune response in mucosaGO:00022279.5DEFA1, DEFA3
6intracellular estrogen receptor signaling pathwayGO:00305209.4DEFA1, DEFA3
7killing of cells of other organismGO:00316409.1DEFA1, DEFA3

Sources for West Nile Fever

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet